UBS AM’s Sensus Healthcare SRTS Stock Holding History

UBS AM’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-28	Closed	-$351	–	2725
2022 Q3	$351	Buy	+28	New	+$335	﹤0.01%	2737

Other funds holding SRTS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return

UBS AM's SRTS Position: Q4 2022 in Review

UBS AM sold out of Sensus Healthcare (SRTS) in Q4 2022, closing a stake of 28 shares — an estimated $351 sold.

UBS AM first reported a position in SRTS in Q3 2022 and held it in 1 quarter. The position peaked at $351 in Q3 2022. 67 funds tracked by Wall St. Rank hold SRTS as of Q4 2022.

UBS AM reported no remaining Sensus Healthcare position as of Q4 2022 after selling out during the quarter.
UBS AM sold 28 Sensus Healthcare shares in Q4 2022, an estimated $351.
UBS AM first reported a position in Sensus Healthcare in Q3 2022 and held it in 1 quarter.
UBS AM's Sensus Healthcare position peaked at $351 in Q3 2022.
67 funds tracked by Wall St. Rank held Sensus Healthcare as of Q4 2022.

Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.